• Explore /
  • Poster
  • / Feasibility and efficacy of high doses of antimetabolites followed by high-dose sequential chemoimmunotherapy (R-HDS) and autologous stem cell transplant (ASCT) in patients (pts) with systemic B-cell lymphoma (BCL) and central nervous system (CNS) involvement: A multicenter phase II trial.

Feasibility and efficacy of high doses of antimetabolites followed by high-dose sequential chemoimmunotherapy (R-HDS) and autologous stem cell transplant (ASCT) in patients (pts) with systemic B-cell lymphoma (BCL) and central nervous system (CNS) involvement: A multicenter phase II trial.

Abstract Poster

Authors

null

Andres J.M. Ferreri

Università Vita e Salute; San Raffaele Scientific Institute, Milano, Italy

Andres J.M. Ferreri , Giovanni Donadoni , Maria Giuseppina Cabras , Caterina Patti , Michael Mian , Renato Zambello , Corrado Tarella , Massimo A. Di Nicola , Alfonso D'Arco , Marta Bruno Ventre , Marco Foppoli , Alessandro Fanni , Gianluca Doa , Antonio Mulè , Federico Caligaris-Cappio , Fabio Ciceri

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lymphoma and Plasma Cell Disorders

Track

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Sub Track

Lymphoma

Clinical Trial Registration Number

NCT00801216

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 8577)

DOI

10.1200/jco.2014.32.15_suppl.8577

Abstract #

8577

Poster Bd #

264

Abstract Disclosures

Similar Posters

First Author: Agnieszka Korfel

First Author: Shaha Nabeel

First Author: Ruemu Ejedafeta Birhiray

First Author: Philippe Armand